Innovus Pharmaceuticals (OTC:INNV) said today that its GlucoGorx glucose monitoring kit, which includes a glucose meter, test strips and a lancet device, won 510(k) approval from the FDA.
The San Diego, Calif.-based company plans to launch its blood sugar monitoring kit in the second half of this year.
Get the full story at our sister site, Drug Delivery Business News.
The post Innovus Pharma wins FDA nod for glucose monitoring kit appeared first on MassDevice.
from MassDevice https://ift.tt/2GTG3tb
Cap comentari:
Publica un comentari a l'entrada